Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Maverix Biomics
Maverix Biomics

Maverix Biomics

Series A

Maverix Biomics Inc. specializes in biologic research, bioinformatics, and software development in California.

HQ
San Mateo, CA, US
Founded
2012
Overview
Compare
Fundraising
Employees

Maverix Biomics Inc., founded in San Mateo, California, is dedicated to advancing biologic research and healthcare through cutting-edge bioinformatics and enterprise application software development. The company's core mission is to enable researchers and healthcare providers with superior Next Generation Sequencing (NGS) data analysis capabilities. Their product offerings include the RNA-Seq Analysis Kit, DNA Variant Analysis Kit, and the comprehensive Maverix Dx Platform, which provide a seamless solution from bio sample to insight, addressing traditional research bottlenecks and accelerating scientific and healthcare advancements.

Notable figures affiliated with Maverix Biomics include key researchers and bioinformatics experts who drive the company's innovative solutions. The company has garnered attention from significant investors in the biotech and healthcare sectors, contributing to its growth and development. Maverix Biomics' achievements include the successful deployment of their NGS data analysis tools in various research and clinical settings, significantly impacting the pace and quality of scientific discoveries and healthcare improvements.

Maverix Biomics - Similar Companies

BioTuring logo

BioTuring

bioturing.com

Dnanexus logo

Dnanexus

dnanexus.com

Biomiic logo

Biomiic

InSyBio logo

InSyBio

insybio.gr

Bioinfoexperts logo

Bioinfoexperts

bioinfox.com

eBioinformatics logo

eBioinformatics

MiLaboratories logo

MiLaboratories

milaboratories.com

Golden Helix logo

Golden Helix

goldenhelix.com

GenomeNext logo

GenomeNext

Stellaromics logo

Stellaromics

stellaromics.com

Insightful Science logo

Insightful Science

Watershed Informatics logo

Watershed Informatics

watershed.bio

NGX Bio logo

NGX Bio

Eclipse Bioinnovations logo

Eclipse Bioinnovations

eclipsebio.com

Seven Bridges logo

Seven Bridges

sevenbridges.com

Maverix Biomics - Quick Facts

Who are Maverix Biomics' competitors?

Companies similar to Maverix Biomics include BioTuring, Dnanexus, Biomiic and InSyBio.

When was Maverix Biomics founded?

Maverix Biomics was founded in 2012.

Where is Maverix Biomics' headquarters located?

Maverix Biomics' headquarters is located in San Mateo, CA, US.

When was Maverix Biomics' last funding round?

Maverix Biomics' most recent funding round was for $6M (USD) in January 2014.

How much has Maverix Biomics raised to-date?

As of Jan 7, 2014, Maverix Biomics has raised a total of $14M (USD).

How many employees does Maverix Biomics have?

Maverix Biomics has 24 employees as of Feb 5, 2024.

Maverix Biomics - Classification

Technology
  • AI
  • Analytics
Geographic Exposure
  • United States
Model
  • Platform
Revenue
  • Recurring
Customer
  • Enterprise
Main Product
  • Bioinformatics
  • Software
Tags
  • Biotech
  • Data
  • Healthcare
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541500Computer Systems Design and Related Services
  • 541000Professional, Scientific, and Technical Services
  • 541510Computer Systems Design and Related Services
  • 541511Custom Computer Programming Services
SIC
  • 7300Business Services
  • 7370Computer Programming, Data Processing, And Other Computer Related
  • 7371Computer Programming Services
Show 5 more industry codes
NAICS
  • 513200Software Publishers
  • 510000Information
  • 513000Publishing Industries
  • 513210Software Publishers
SIC
  • 7372Prepackaged Software